SR8278
Chemical compound
From Wikipedia, the free encyclopedia
SR-8278 is an experimental drug that was developed as an antagonist of Rev-ErbAα.[1] It has been used to demonstrate potential applications of Rev-ErbAα antagonists in the treatment of conditions such as Duchenne muscular dystrophy and Alzheimer's disease.[2][3]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H19NO3S2 |
| Molar mass | 361.47 g·mol−1 |
| 3D model (JSmol) | |
| |
| |